Karyotypic characterization of infant embryonal rhabdomyosarcoma

Cancer Genetics and Cytogenetics
Andrea MunteanDavid R Betts

Abstract

Despite embryonal rhabdomyosarcoma (eRMS) representing the most frequent form of RMS, the karyotypic characterization of this tumor subtype is still incomplete. We report the karyotypic analysis of two new cases of infant-onset eRMS. Both cases had a hyperdiploid karyotype, including gain of chromosomes 2 and 8. Only one of the cases showed a structural aberration, an unbalanced rearrangement involving 4p. These cases, together with a review of the literature, suggest that a karyotypic subgroup exists in infant eRMS that is defined by hyperdiploidy (<53 chromosomes) and includes gain of chromosomes 2, 8, 11, and 17, with few or no structural aberrations. Hence, this report illustrates that distinct karyotypic subgroups may be found in eRMS, which ultimately may be shown to have prognostic relevance.

References

Feb 1, 1988·Cancer Genetics and Cytogenetics·Y HayashiK Yamamoto
Jan 1, 1994·Medical and Pediatric Oncology·N P BownA D Pearson
Sep 28, 1999·Oncogene·G Merlino, L J Helman
Jul 10, 2003·Cancer Genetics and Cytogenetics·Rosario Gil-BensoAntonio Llombart-Bosch
Jan 31, 2004·Pediatric Blood & Cancer·D JoshiUNKNOWN Soft Tissue Sarcoma Committee of the Children's Oncology Group
Jul 5, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D OrbachM C G Stevens
Mar 14, 2007·Cancer Genetics and Cytogenetics·Kayla M KapelsJulia A Bridge
Oct 1, 1995·Journal of Glaucoma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.